Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Liabilities from Discontinued Operations: 2022-2024

  • Mimedx Group's Liabilities from Discontinued Operations was N/A to $217,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $217,000, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2023, which is 8.59% down from last year.
  • According to the latest figures from Q2 2024, Mimedx Group's Liabilities from Discontinued Operations is $217,000, which was down 36.92% from $344,000 recorded in Q1 2024.
  • Mimedx Group's Liabilities from Discontinued Operations' 5-year high stood at $1.5 million during Q4 2022, with a 5-year trough of $217,000 in Q2 2024.
  • For the 3-year period, Mimedx Group's Liabilities from Discontinued Operations averaged around $848,000, with its median value being $848,000 (2023).
  • Data for Mimedx Group's Liabilities from Discontinued Operations shows a maximum YoY fell of 8.59% (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Mimedx Group's Liabilities from Discontinued Operations stood at $1.5 million in 2022, then fell by 8.59% to $1.4 million in 2023, then reached $217,000 in 2024.
  • Its Liabilities from Discontinued Operations stands at $217,000 for Q2 2024, versus $344,000 for Q1 2024 and $1.4 million for Q4 2023.